Search hospitals > Ohio > Cleveland
University Hospitals Cleveland Medical Center
Claim this profileCleveland, Ohio 44106
Global Leader in Tumors
Global Leader in Non-Small Cell Lung Cancer
Conducts research for Lymphoma
Conducts research for Cancer
Conducts research for Lung Cancer
927 reported clinical trials
121 medical researchers
Summary
University Hospitals Cleveland Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Tumors, Non-Small Cell Lung Cancer, Lymphoma, Cancer, Lung Cancer and other specialties. University Hospitals Cleveland Medical Center is involved with conducting 927 clinical trials across 1,004 conditions. There are 121 research doctors associated with this hospital, such as Amit Mahipal, MD, Afshin Dowlati, MD, Lauren Henke, MD, and Brenda W. Cooper.Area of expertise
1Tumors
Global LeaderStage IV
Stage III
HER2 positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
KRAS positive
Top PIs
Amit Mahipal, MDMayo Clinic2 years of reported clinical research
Studies Tumors
Studies Bile Duct Cancer
19 reported clinical trials
36 drugs studied
Afshin Dowlati, MDUniversity Hospitals Cleveland Medical Center3 years of reported clinical research
Studies Tumors
Studies Non-Small Cell Lung Cancer
15 reported clinical trials
29 drugs studied
Lauren Henke, MDWashington University School of Medicine2 years of reported clinical research
Studies Cancer
Studies Lung Cancer
16 reported clinical trials
28 drugs studied
Brenda W. CooperCase Western Reserve University5 years of reported clinical research
Studies Leukemia
Studies Myeloid Leukemia
11 reported clinical trials
30 drugs studied
Clinical Trials running at University Hospitals Cleveland Medical Center
Bladder Cancer
Multiple Myeloma
Breast Cancer
Crohn's Disease
Coronavirus
Non-Small Cell Lung Cancer
Cancer
Ulcerative Colitis
Ovarian Cancer
Lymphoma
TAR-200 + Cetrelimab vs BCG
for Bladder Cancer
This trial is testing a new bladder cancer treatment using a special device to deliver a drug directly into the bladder, either alone or with an immune-boosting drug. It targets patients with high-risk bladder cancer who haven't had BCG treatment before. The device ensures a steady release of the drug, while the immune-boosting drug helps the body fight cancer.
Recruiting2 awards Phase 36 criteria
Pembrolizumab + BCG
for Bladder Cancer
Researchers are looking for new ways to treat high-risk non muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread to the bladder muscle or outside of the bladder. High-risk means NMIBC may have a high chance of getting worse or coming back after treatment. The goals of this study are to learn: 1. If more people who receive pembrolizumab with Bacillus Calmette-Guerin (BCG) have no signs of cancer in their body and live longer without the cancer growing, spreading, or coming back compared to people who receive BCG alone. 2. About the safety and how well people tolerate BCG alone or in combination with pembrolizumab.
Recruiting2 awards Phase 39 criteria
TOS-358
for Cancer
This trial tests TOS-358, a new drug for adults with specific cancers that have a genetic mutation. It aims to find the safest dose and see how well patients tolerate it. The drug works by blocking a gene that helps cancer cells grow.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University Hospitals Cleveland Medical Center?
University Hospitals Cleveland Medical Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Tumors, Non-Small Cell Lung Cancer, Lymphoma, Cancer, Lung Cancer and other specialties. University Hospitals Cleveland Medical Center is involved with conducting 927 clinical trials across 1,004 conditions. There are 121 research doctors associated with this hospital, such as Amit Mahipal, MD, Afshin Dowlati, MD, Lauren Henke, MD, and Brenda W. Cooper.
Where is University Hospitals Cleveland Medical Center located?
University Hospitals Cleveland Medical Center is located at 11100 Euclid Ave, Cleveland, Ohio. For real-time driving directions, consider using Waze to navigate to the main campus.
Who should I call to ask about financial aid or insurance network?
**University Hospitals Cleveland Medical Center Financial Assistance and Insurance Contact Information:**
- **Financial Counselors:** For assistance with specialized service estimates, insurance eligibility, and financial assistance, call 1-866-771-7266 (Monday – Friday: 8 a.m. – 4:30 p.m.).
- **Hospital Care Assurance Program (HCAP):** For information, contact 216-844-2447, 216-844-8299, or toll-free 1-800-859-5906.
- **General Billing Inquiries:** Reach the UH Customer Service Department at 216-844-8299 (Monday – Friday: 8 a.m. – 5:30 p.m.).
What insurance does University Hospitals Cleveland Medical Center accept?
The University Hospitals Cleveland Medical Center accepts a variety of major insurance plans such as Aetna, Anthem, Cigna, Medical Mutual of Ohio, and United Healthcare. For a detailed list of accepted insurance plans, please consult our health insurance directory. Always verify with your insurance provider to confirm coverage details and financial responsibilities for your care.
What awards or recognition has University Hospitals Cleveland Medical Center received?
University Hospitals Cleveland Medical Center is ranked among the nation's Best Hospitals in seven adult specialties by U.S. News & World Report. It has been recognized as a Magnet organization for nursing excellence and received the Lantern Award for exceptional emergency department care. Additionally, it has been named one of the World's Most Ethical Companies by the Ethisphere Institute.